Novartis: Pipeline Progress And Buyback Drive Upside

Following our summer break, we are resuming coverage of Novartis (NYSE: NVS ) ( OTCPK:NVSEF ). Although Trump enacted a 39% duty on Swiss goods in early August, the measure spares pharmaceuticals, given the USA's reliance on SwissBuy-side hedge professionals conducting fundamental, income oriented, long term analysis across sectors globally in developed markets. Please shoot us a message or leave a comment to discuss ideas.DISCLOSURE: All of our articles are a matter of opinion, informed as they might be, a ...